Uploaded November 2026 | Updated November 2026, 3 hours ago
The FDA will now require makers of GLP-1s like Ozempic and Zepbound to add a warning to their labels about a rare side effect that can cause vision loss potentially associated with the drugs.
Mindy Basara has the latest in today's Medical Minute. Follow updates in the WBAL-TV 11 News app, on WBALTV.com and the link in bio.
The FDA will now require makers of GLP-1s like Ozempic and Zepbound to add a warning to their labels about a rare side effect that can cause vision loss potentially associated with the drugs.
Mindy Basara has the latest in today's Medical Minute. Follow updates in the WBAL-TV 11 News app, on WBALTV.com and the link in bio.










